[Effects of MY-1250, a main active metabolite of MY-5116, a new anti-allergic drug, on histamine release from rat peritoneal exudate cells and the degranulation of mesenteric mast cells].
D000818:Animals; D006636:Histamine Release / Q000187:drug effects*; D066298:In Vitro Techniques; D008297:Male; D008407:Mast Cells / Q000187:drug effects*; D010529:Peritoneal Cavity / Q000166:cytology; D011804:Quinolines / Q000494:pharmacology*; D015363:Quinolones; D051381:Rats; D011919:Rats, Inbred Strains
D011804:Quinolines; D015363:Quinolones; C049488:MY 1250